ScholarIQanswers from OpenAlex & ORCID
Sandra P. D’Angelo
ResearcherPublications, citations & collaboration network
Sandra P. D’Angelo is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Sandra P. D’Angelo have?
ScholarIQindexed works
Sandra P. D’Angelo has 430 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Sandra P. D’Angelo have?
ScholarIQcitation count
Sandra P. D’Angelo has 19,338 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Sandra P. D’Angelo?
ScholarIQh-index
Sandra P. D’Angelo has an h-index of 54 in OpenAlex.
What is the i10-index of Sandra P. D’Angelo?
ScholarIQi10-index
Sandra P. D’Angelo has an i10-index of 134 in OpenAlex.
What is the ORCID of Sandra P. D’Angelo?
ScholarIQorcid
The ORCID for Sandra P. D’Angelo is on the source record.
What is the OpenAlex record for Sandra P. D’Angelo?
ScholarIQopenalex
The OpenAlex for Sandra P. D’Angelo is on the source record.
What are the most-cited papers on Sandra P. D’Angelo?
ScholarIQmost cited works
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
Robert Samstein, Chung‐Han Lee, Alexander N. Shoushtari, Matthew D. Hellmann, Ronglai Shen, Yelena Y. Janjigian, David Barron, Ahmet Zehir, Emmet Jordan, Antonio Omuro, Thomas Kaley, Sviatoslav M. Kendall, Robert J. Motzer, A. Ari Hakimi, Martin H. Voss, Paul Russo, Jonathan E. Rosenberg, Gopa Iyer, Bernard H. Bochner, Dean F. Bajorin, Hikmat Al‐Ahmadie, Jamie E. Chaft, Charles M. Rudin, Gregory J. Riely, Shrujal S. Baxi, Alan L. Ho, Richard J. Wong, David G. Pfister, Jedd D. Wolchok, Christopher A. Barker, Philip H. Gutin, Cameron Brennan, Viviane Tabar, Ingo K. Mellinghoff, Lisa M. DeAngelis, Charlotte E. Ariyan, Nancy Y. Lee, William D. Tap, Mrinal M. Gounder, Sandra P. D’Angelo, Leonard B. Saltz, Zsofia K. Stadler, Howard I. Scher, José Baselga, Pedram Razavi, Christopher A. Klebanoff, Rona Yaeger, Neil H. Segal, Geoffrey Y. Ku, Ronald P. DeMatteo, Marc Ladanyi, Naiyer A. Rizvi, Michael F. Berger, Nadeem Riaz, David B. Solit, Timothy A. Chan, Luc G.T. Morris
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial
Hussein A. Tawbi, Melissa Burgess, Vanessa Bolejack, Brian A. Van Tine, Scott M. Schuetze, James Hu, Sandra P. D’Angelo, Steven Attia, Richard F. Riedel, Dennis A. Priebat, Sujana Movva, Lara E. Davis, Scott H. Okuno, Damon R. Reed, John Crowley, Lisa H. Butterfield, Ruth Salazar, Jaime Rodriguez‐Canales, Alexander J. Lazar, Ignacio I. Wistuba, Laurence H. Baker, Robert G. Maki, Denise K. Reinke, Shreyaskumar Patel
Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial
Sandra P. D’Angelo, Dejka M. Araujo, Albiruni R. Abdul Razak, Mark Agulnik, Steven Attia, Jean‐Yves Blay, Irene Carrasco García, John A. Charlson, Edwin Choy, George D. Demetri, Mihaela Druta, Édouard Forcade, Kristen N. Ganjoo, John Glod, Vicki L. Keedy, Axel Le Cesne, David A. Liebner, Víctor Moreno, Seth M. Pollack, Scott M. Schuetze, Gary K. Schwartz, Sandra J. Strauss, William D. Tap, Fiona Thistlethwaite, Claudia Maria Valverde Morales, Michael J. Wagner, Breelyn A. Wilky, Cheryl McAlpine, Laura Hudson, Jean‐Marc Navenot, Tianjiao Wang, Jane P. F. Bai, Stavros Rafail, Ruoxi Wang, Amy Sun, Lilliam Fernandes, Erin Van Winkle, Erica Elefant, Colin Lunt, Elliot Norry, Dennis Williams, Swethajit Biswas, Brian Andrew Van Tine
Associations Between Mutations and Histologic Patterns of Mucin in Lung Adenocarcinoma
Kyuichi Kadota, Yi‐Chen Yeh, Sandra P. D’Angelo, André L. Moreira, Deborah Kuk, Camelia S. Sima, Gregory J. Riely, Maria E. Arcila, Mark G. Kris, Valerie W. Rusch, Prasad S. Adusumilli, William D. Travis